Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration

Bradford Dugan; Christine A. Welch; A. Rahman; Michael Korona; Amy R. Deipolyi

doi:10.4274/dir.2026.263734

March 23, 2026Diagnostic and Interventional RadiologyOpen Access

Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the effectiveness of desmopressin in preventing bleeding after non-focal renal biopsy.
Administered desmopressin (DDAVP) before the renal biopsy procedure.
Monitored patients for clinically significant bleeding post-biopsy.
Desmopressin administration significantly decreased the occurrence of hemorrhagic complications.
Supports the use of desmopressin as a prophylactic measure in renal biopsy.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Routine administration of desmopressin reduces bleeding complications in renal biopsy, suggesting a simple prophylactic approach.

Abstract

Routine DDAVP administration before NRFB significantly reduces clinically significant bleeding, supporting its potential role as a simple prophylactic strategy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dugan et al. (2026) studied this question.

synapsesocial.com/papers/69c37b11b34aaaeb1a67d15f https://doi.org/10.4274/dir.2026.263734

View Full Paper

Ask AI

Bookmark

Share

Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading